(Q45265577)

11 December 2017

title

The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women (English)

1 reference

11 December 2017

1 reference

Manuel Muñoz-Torres

8

0 references

Juan de Dios Luna

object named as

Juan de Dios Luna

6

0 references

author name string

Pedro Mezquita-Raya

1

1 reference

11 December 2017

Magdalena de la Higuera

2

1 reference

11 December 2017

Diego Fernández García

3

1 reference

11 December 2017

Guillermo Alonso

4

1 reference

11 December 2017

María Estrella Ruiz-Requena

5

1 reference

11 December 2017

Fernando Escobar-Jiménez

7

1 reference

11 December 2017

language of work or name

English

0 references

publication date

12 February 2005

1 reference

Osteoporosis International

11 December 2017

published in

1 reference

11 December 2017

volume

16

1 reference

11 December 2017

issue

11

1 reference

11 December 2017

page(s)

1368-1374

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-005-1844-1

11 December 2017

exact match

0 references

cites work

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

12 December 2020

Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation

1 reference

12 December 2020

The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts

1 reference

12 December 2020

Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

The effect of a single dose of osteoprotegerin in postmenopausal women

1 reference

12 December 2020

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

1 reference

12 December 2020

Correlates of osteoprotegerin levels in women and men.

1 reference

12 December 2020

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

12 December 2020

Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells

1 reference

12 December 2020

Serum levels of osteoprotegerin increase with age in a healthy adult population

1 reference

12 December 2020

High serum osteoprotegerin and low RANKL in primary biliary cirrhosis

1 reference

12 December 2020

Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis.

1 reference

12 December 2020

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

1 reference

12 December 2020

Differences in skeletal kinetics between vertebral and humeral bone measured by 18F-fluoride positron emission tomography in postmenopausal women

1 reference

12 December 2020

Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women

1 reference

12 December 2020

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

1 reference

12 December 2020

The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men.

1 reference

12 December 2020

Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels.

1 reference

12 December 2020

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

12 December 2020

Sex steroids and the construction and conservation of the adult skeleton

1 reference

12 December 2020

Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples.

1 reference

12 December 2020

Clinical use of biochemical markers of bone remodeling: current status and future directions

1 reference

12 December 2020

Soluble RANKL and risk of nontraumatic fracture

1 reference

12 December 2020

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

1 reference

12 December 2020

10.1007/S00198-005-1844-1

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1025833781

0 references

1 reference